Drug-Eluting Balloons Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
SUMMARY
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Drug-Eluting Balloons market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Drug-Eluting Balloons market segmented into
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Drug-Eluting Balloons market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Drug-Eluting Balloons market segmented into
- Semi-Compliant Balloons
- Non-Compliant Balloons
- Treatment of In-stent Restenosis (ISR)
- Treatment of Small Vessel Disease (SVD)
- Treatment of Bifurcation Stenoses
- Treatment of Primary Coronary Artery Disease
- North America [U.S., Canada, Mexico]
- Europe [Germany, UK, France, Italy, Rest of Europe]
- Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
- South America [Brazil, Argentina, Rest of Latin America]
- Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
- Boston Scientific
- Medtronic
- Cook Medical
- C.R. Bard
- B. Braun
- Eurocor GmbH
- Blue Medical
- Bayer
- Aachen Resonance
- Acrostak
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL DRUG-ELUTING BALLOONS INDUSTRY
2.1 Summary about Drug-Eluting Balloons Industry
2.2 Drug-Eluting Balloons Market Trends
2.2.1 Drug-Eluting Balloons Production & Consumption Trends
2.2.2 Drug-Eluting Balloons Demand Structure Trends
2.3 Drug-Eluting Balloons Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Semi-Compliant Balloons
4.2.2 Non-Compliant Balloons
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Treatment of In-stent Restenosis (ISR)
4.3.2 Treatment of Small Vessel Disease (SVD)
4.3.3 Treatment of Bifurcation Stenoses
4.3.4 Treatment of Primary Coronary Artery Disease
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Semi-Compliant Balloons
5.2.2 Non-Compliant Balloons
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Treatment of In-stent Restenosis (ISR)
5.3.2 Treatment of Small Vessel Disease (SVD)
5.3.3 Treatment of Bifurcation Stenoses
5.3.4 Treatment of Primary Coronary Artery Disease
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Semi-Compliant Balloons
6.2.2 Non-Compliant Balloons
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Treatment of In-stent Restenosis (ISR)
6.3.2 Treatment of Small Vessel Disease (SVD)
6.3.3 Treatment of Bifurcation Stenoses
6.3.4 Treatment of Primary Coronary Artery Disease
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Semi-Compliant Balloons
7.2.2 Non-Compliant Balloons
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Treatment of In-stent Restenosis (ISR)
7.3.2 Treatment of Small Vessel Disease (SVD)
7.3.3 Treatment of Bifurcation Stenoses
7.3.4 Treatment of Primary Coronary Artery Disease
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Semi-Compliant Balloons
8.2.2 Non-Compliant Balloons
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Treatment of In-stent Restenosis (ISR)
8.3.2 Treatment of Small Vessel Disease (SVD)
8.3.3 Treatment of Bifurcation Stenoses
8.3.4 Treatment of Primary Coronary Artery Disease
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Semi-Compliant Balloons
9.2.2 Non-Compliant Balloons
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Treatment of In-stent Restenosis (ISR)
9.3.2 Treatment of Small Vessel Disease (SVD)
9.3.3 Treatment of Bifurcation Stenoses
9.3.4 Treatment of Primary Coronary Artery Disease
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Boston Scientific
10.1.2 Medtronic
10.1.3 Cook Medical
10.1.4 C.R. Bard
10.1.5 B. Braun
10.1.6 Eurocor GmbH
10.1.7 Blue Medical
10.1.8 Bayer
10.1.9 Aachen Resonance
10.1.10 Acrostak
10.2 Drug-Eluting Balloons Sales Date of Major Players (2017-2020e)
10.2.1 Boston Scientific
10.2.2 Medtronic
10.2.3 Cook Medical
10.2.4 C.R. Bard
10.2.5 B. Braun
10.2.6 Eurocor GmbH
10.2.7 Blue Medical
10.2.8 Bayer
10.2.9 Aachen Resonance
10.2.10 Acrostak
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL DRUG-ELUTING BALLOONS INDUSTRY
2.1 Summary about Drug-Eluting Balloons Industry
2.2 Drug-Eluting Balloons Market Trends
2.2.1 Drug-Eluting Balloons Production & Consumption Trends
2.2.2 Drug-Eluting Balloons Demand Structure Trends
2.3 Drug-Eluting Balloons Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Semi-Compliant Balloons
4.2.2 Non-Compliant Balloons
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Treatment of In-stent Restenosis (ISR)
4.3.2 Treatment of Small Vessel Disease (SVD)
4.3.3 Treatment of Bifurcation Stenoses
4.3.4 Treatment of Primary Coronary Artery Disease
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Semi-Compliant Balloons
5.2.2 Non-Compliant Balloons
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Treatment of In-stent Restenosis (ISR)
5.3.2 Treatment of Small Vessel Disease (SVD)
5.3.3 Treatment of Bifurcation Stenoses
5.3.4 Treatment of Primary Coronary Artery Disease
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Semi-Compliant Balloons
6.2.2 Non-Compliant Balloons
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Treatment of In-stent Restenosis (ISR)
6.3.2 Treatment of Small Vessel Disease (SVD)
6.3.3 Treatment of Bifurcation Stenoses
6.3.4 Treatment of Primary Coronary Artery Disease
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Semi-Compliant Balloons
7.2.2 Non-Compliant Balloons
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Treatment of In-stent Restenosis (ISR)
7.3.2 Treatment of Small Vessel Disease (SVD)
7.3.3 Treatment of Bifurcation Stenoses
7.3.4 Treatment of Primary Coronary Artery Disease
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Semi-Compliant Balloons
8.2.2 Non-Compliant Balloons
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Treatment of In-stent Restenosis (ISR)
8.3.2 Treatment of Small Vessel Disease (SVD)
8.3.3 Treatment of Bifurcation Stenoses
8.3.4 Treatment of Primary Coronary Artery Disease
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Semi-Compliant Balloons
9.2.2 Non-Compliant Balloons
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Treatment of In-stent Restenosis (ISR)
9.3.2 Treatment of Small Vessel Disease (SVD)
9.3.3 Treatment of Bifurcation Stenoses
9.3.4 Treatment of Primary Coronary Artery Disease
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Boston Scientific
10.1.2 Medtronic
10.1.3 Cook Medical
10.1.4 C.R. Bard
10.1.5 B. Braun
10.1.6 Eurocor GmbH
10.1.7 Blue Medical
10.1.8 Bayer
10.1.9 Aachen Resonance
10.1.10 Acrostak
10.2 Drug-Eluting Balloons Sales Date of Major Players (2017-2020e)
10.2.1 Boston Scientific
10.2.2 Medtronic
10.2.3 Cook Medical
10.2.4 C.R. Bard
10.2.5 B. Braun
10.2.6 Eurocor GmbH
10.2.7 Blue Medical
10.2.8 Bayer
10.2.9 Aachen Resonance
10.2.10 Acrostak
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
LIST OF TABLES
1.Table Drug-Eluting Balloons Product Type Overview
2.Table Drug-Eluting Balloons Product Type Market Share List
3.Table Drug-Eluting Balloons Product Type of Major Players
4.Table Brief Introduction of Boston Scientific
5.Table Brief Introduction of Medtronic
6.Table Brief Introduction of Cook Medical
7.Table Brief Introduction of C.R. Bard
8.Table Brief Introduction of B. Braun
9.Table Brief Introduction of Eurocor GmbH
10.Table Brief Introduction of Blue Medical
11.Table Brief Introduction of Bayer
12.Table Brief Introduction of Aachen Resonance
13.Table Brief Introduction of Acrostak
14.Table Products & Services of Boston Scientific
15.Table Products & Services of Medtronic
16.Table Products & Services of Cook Medical
17.Table Products & Services of C.R. Bard
18.Table Products & Services of B. Braun
19.Table Products & Services of Eurocor GmbH
20.Table Products & Services of Blue Medical
21.Table Products & Services of Bayer
22.Table Products & Services of Aachen Resonance
23.Table Products & Services of Acrostak
24.Table Market Distribution of Major Players
25.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
26.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
27.Table Global Drug-Eluting Balloons Market Forecast (Million USD) by Region 2021f-2026f
28.Table Global Drug-Eluting Balloons Market Forecast (Million USD) Share by Region 2021f-2026f
29.Table Global Drug-Eluting Balloons Market Forecast (Million USD) by Demand 2021f-2026f
30.Table Global Drug-Eluting Balloons Market Forecast (Million USD) Share by Demand 2021f-2026f
1.Table Drug-Eluting Balloons Product Type Overview
2.Table Drug-Eluting Balloons Product Type Market Share List
3.Table Drug-Eluting Balloons Product Type of Major Players
4.Table Brief Introduction of Boston Scientific
5.Table Brief Introduction of Medtronic
6.Table Brief Introduction of Cook Medical
7.Table Brief Introduction of C.R. Bard
8.Table Brief Introduction of B. Braun
9.Table Brief Introduction of Eurocor GmbH
10.Table Brief Introduction of Blue Medical
11.Table Brief Introduction of Bayer
12.Table Brief Introduction of Aachen Resonance
13.Table Brief Introduction of Acrostak
14.Table Products & Services of Boston Scientific
15.Table Products & Services of Medtronic
16.Table Products & Services of Cook Medical
17.Table Products & Services of C.R. Bard
18.Table Products & Services of B. Braun
19.Table Products & Services of Eurocor GmbH
20.Table Products & Services of Blue Medical
21.Table Products & Services of Bayer
22.Table Products & Services of Aachen Resonance
23.Table Products & Services of Acrostak
24.Table Market Distribution of Major Players
25.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
26.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
27.Table Global Drug-Eluting Balloons Market Forecast (Million USD) by Region 2021f-2026f
28.Table Global Drug-Eluting Balloons Market Forecast (Million USD) Share by Region 2021f-2026f
29.Table Global Drug-Eluting Balloons Market Forecast (Million USD) by Demand 2021f-2026f
30.Table Global Drug-Eluting Balloons Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
1.Figure Global Drug-Eluting Balloons Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Drug-Eluting Balloons Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Drug-Eluting Balloons Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Drug-Eluting Balloons Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Drug-Eluting Balloons Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Drug-Eluting Balloons Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Drug-Eluting Balloons Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Semi-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Non-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Treatment of In-stent Restenosis (ISR) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Treatment of Small Vessel Disease (SVD) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Treatment of Bifurcation Stenoses Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Treatment of Primary Coronary Artery Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Semi-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Non-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Treatment of In-stent Restenosis (ISR) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Treatment of Small Vessel Disease (SVD) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Treatment of Bifurcation Stenoses Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Treatment of Primary Coronary Artery Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Semi-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Non-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Treatment of In-stent Restenosis (ISR) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Treatment of Small Vessel Disease (SVD) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Treatment of Bifurcation Stenoses Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Treatment of Primary Coronary Artery Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Semi-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Non-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Treatment of In-stent Restenosis (ISR) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Treatment of Small Vessel Disease (SVD) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Treatment of Bifurcation Stenoses Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Treatment of Primary Coronary Artery Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Semi-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Non-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Treatment of In-stent Restenosis (ISR) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Treatment of Small Vessel Disease (SVD) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Treatment of Bifurcation Stenoses Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Treatment of Primary Coronary Artery Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Semi-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Non-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Treatment of In-stent Restenosis (ISR) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Treatment of Small Vessel Disease (SVD) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure
1.Figure Global Drug-Eluting Balloons Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Drug-Eluting Balloons Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Drug-Eluting Balloons Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Drug-Eluting Balloons Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Drug-Eluting Balloons Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Drug-Eluting Balloons Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Drug-Eluting Balloons Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Semi-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Non-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Treatment of In-stent Restenosis (ISR) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Treatment of Small Vessel Disease (SVD) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Treatment of Bifurcation Stenoses Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Treatment of Primary Coronary Artery Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Semi-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Non-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Treatment of In-stent Restenosis (ISR) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Treatment of Small Vessel Disease (SVD) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Treatment of Bifurcation Stenoses Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Treatment of Primary Coronary Artery Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Semi-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Non-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Treatment of In-stent Restenosis (ISR) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Treatment of Small Vessel Disease (SVD) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Treatment of Bifurcation Stenoses Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Treatment of Primary Coronary Artery Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Semi-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Non-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Treatment of In-stent Restenosis (ISR) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Treatment of Small Vessel Disease (SVD) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Treatment of Bifurcation Stenoses Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Treatment of Primary Coronary Artery Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Semi-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Non-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Treatment of In-stent Restenosis (ISR) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Treatment of Small Vessel Disease (SVD) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Treatment of Bifurcation Stenoses Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Treatment of Primary Coronary Artery Disease Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Semi-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Non-Compliant Balloons Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Treatment of In-stent Restenosis (ISR) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Treatment of Small Vessel Disease (SVD) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure
